The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

42 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core.EBI
Vitae Pharmaceuticals
Discovery of a Novel, Orally Efficacious Liver X Receptor (LXR)ß Agonist.EBI
Vitae Pharmaceuticals
Identification of spirooxindole and dibenzoxazepine motifs as potent mineralocorticoid receptor antagonists.EBI
Vitae Pharmaceuticals
Structure-based design and synthesis of 1,3-oxazinan-2-one inhibitors of 11ß-hydroxysteroid dehydrogenase type 1.EBI
Vitae Pharmaceuticals
Biphenyl/diphenyl ether renin inhibitors: filling the S1 pocket of renin via the S3 pocket.EBI
Vitae Pharmaceuticals
Discovery and optimization of adamantyl carbamate inhibitors of 11ß-HSD1.EBI
Vitae Pharmaceuticals
Spirocyclic ureas: orally bioavailable 11beta-HSD1 inhibitors identified by computer-aided drug design.EBI
Vitae Pharmaceuticals
Optimization of orally bioavailable alkyl amine renin inhibitors.EBI
Vitae Pharmaceuticals
Non-canonical modulators of nuclear receptors.EBI
Vitae Pharmaceuticals
The use of spirocyclic scaffolds in drug discovery.EBI
Vitae Pharmaceuticals
Structure-based design of β-site APP cleaving enzyme 1 (BACE1) inhibitors for the treatment of Alzheimer's disease.EBI
Vitae Pharmaceuticals
Discovery of BI 135585, an in vivo efficacious oxazinanone-based 11β hydroxysteroid dehydrogenase type 1 inhibitor.EBI
Vitae Pharmaceuticals
Cyclic polypeptides for PCSK9 inhibitionBDB
Merck Sharp & Dohme
Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancerBDB
The Institute of Cancer Research: Royal Cancer Hospital
Compounds that inhibit Mcl-1 proteinBDB
Amgen
SALT AND CRYSTAL FORM OF DIHYDROPYRIDO[2,3-d]PYRIMIDINE DERIVATEBDB
Nanjing Chia Tai Tianqing Pharmaceutical
CDK2/4/6 inhibitorsBDB
Pfizer
Methods for treating pulmonary hypertensionBDB
Reviva Pharmaceuticals
Tetrahydronaphthyl urea derivativeBDB
Mochida Pharmaceutical
Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonistsBDB
Bristol-Myers Squibb
Tricyclic substituted thiadiazine dioxide compounds as BACE inhibitors, compositions and their useBDB
Merck Sharp & Dohme
New insights into homopiperazine-based 5-HT1A/5-HT7R ligands: synthesis and biological evaluation.BDB
University of Orleans
Structure of the Acinetobacter baumannii dithiol oxidase DsbA bound to elongation factor EF-Tu reveals a novel protein interaction site.BDB
University of Queensland
Capzimin is a potent and specific inhibitor of proteasome isopeptidase Rpn11.BDB
California Institute of Technology
Therapeutic pyrazolyl thienopyridinesBDB
Thesan Pharmaceuticals
Orvinol and thevinol derivatives useful in the treatment of depressionBDB
The University of Bath
Inhibitors of c-fms kinaseBDB
Janssen Pharmaceutica
Indoline scaffold SHP-2 inhibitors and cancer treatment methodBDB
University of South Florida
GABA(C) receptors as drug targets.BDB
University of Sydney
Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2.BDB
Merck Research Laboratories
Pharmacology and functions of metabotropic glutamate receptors.BDB
Emory University
The identification of a novel natural activator of p300 histone acetyltranferase provides new insights into the modulation mechanism of this enzyme.BDB
Universitá
In vivo receptor occupancy of the angiotensin II receptor by nonpeptide antagonists: relationship to in vitro affinities and in vivo pharmacologic potency.BDB
Merck Research Laboratories
Effects of remoxipride and some related new substituted salicylamides on rat brain receptors.BDB
Astra LÄKemedel
Aminomethylpyrimidines as novel DPP-IV inhibitors: a 10(5)-fold activity increase by optimization of aromatic substituents.BDB
Hoffmann-La Roche